找到约 29 条 “DG051” 相关结果 （用时 0.109 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
| M11969 | ChemBridge-5305103 | ChemBridge化合物-5305103 | Screening Compounds and Building Blocks |
| 4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-yl]amino}benzoic acid hydrobromide (5305103) | |||
| ChemBridge特有类药化合物/先导化合物-5305103，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M11976 | ChemBridge-5310510 | ChemBridge化合物-5310510 | Screening Compounds and Building Blocks |
| 3,3'-(1,3-phenylene)bisacrylic acid (5310510) | |||
| ChemBridge特有类药化合物/先导化合物-5310510，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M13009 | ChemBridge-7805127 | ChemBridge化合物-7805127 | Screening Compounds and Building Blocks |
| 4-({[(5-chloro-2-methoxyphenyl)amino]carbonothioyl}amino)-1-ethyl-1H-pyrazole-3-carboxamide (7805127) | |||
| ChemBridge特有类药化合物/先导化合物-7805127，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M13075 | ChemBridge-7925560 | ChemBridge化合物-7925560 | Screening Compounds and Building Blocks |
| 2-(4-phenoxyphenyl)-4a,5,6,7,8,8a-hexahydroquinoxaline 1,4-dioxide (7925560) | |||
| ChemBridge特有类药化合物/先导化合物-7925560，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M13263 | ChemBridge-26330512 | ChemBridge化合物-26330512 | Screening Compounds and Building Blocks |
| 1-(3-{[3-(1-piperidinylcarbonyl)-1-propyl-4,5,6,7-tetrahydro-1H-indazol-5-yl]amino}propyl)-2-pyrrolidinone (26330512) | |||
| ChemBridge特有类药化合物/先导化合物-26330512，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M22144 | DG051 | DG051 | Others |
| DG051 | |||
| M46037 | ChemBridge-6986051 | ChemBridge化合物-6986051 | Screening Compounds and Building Blocks |
| 4-[5-(4-methoxyphenyl)-4,7-dihydrotetrazolo[1,5-a]pyrimidin-7-yl]-N,N-dimethylaniline (6986051) | |||
| ChemBridge特有类药化合物/先导化合物-6986051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46330 | ChemBridge-7827051 | ChemBridge化合物-7827051 | Screening Compounds and Building Blocks |
| N-(4-acetylphenyl)-N'-(2-sec-butylphenyl)thiourea (7827051) | |||
| ChemBridge特有类药化合物/先导化合物-7827051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46378 | ChemBridge-7905192 | ChemBridge化合物-7905192 | Screening Compounds and Building Blocks |
| N-[2,4,6-trioxo-1-phenyl-5-(trifluoromethyl)-2,3,4,5,6,7-hexahydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl]isonicotinamide (7905192) | |||
| ChemBridge特有类药化合物/先导化合物-7905192，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46480 | ChemBridge-7966051 | ChemBridge化合物-7966051 | Screening Compounds and Building Blocks |
| (4-{[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetyl]amino}phenyl)acetic acid (7966051) | |||
| ChemBridge特有类药化合物/先导化合物-7966051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46519 | ChemBridge-7988051 | ChemBridge化合物-7988051 | Screening Compounds and Building Blocks |
| 9-(4-pyridinyl)-2,3,8,9-tetrahydro[1,4]dioxino[2,3-g]quinolin-7(6H)-one (7988051) | |||
| ChemBridge特有类药化合物/先导化合物-7988051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46595 | ChemBridge-8830051 | ChemBridge化合物-8830051 | Screening Compounds and Building Blocks |
| N-[1-(4-pyridinyl)ethyl]-N'-[3-(trifluoromethyl)phenyl]thiourea (8830051) | |||
| ChemBridge特有类药化合物/先导化合物-8830051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46821 | ChemBridge-9051705 | ChemBridge化合物-9051705 | Screening Compounds and Building Blocks |
| N-(2-methoxyethyl)-2,4-dimethylbenzenesulfonamide (9051705) | |||
| ChemBridge特有类药化合物/先导化合物-9051705，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47053 | ChemBridge-9226051 | ChemBridge化合物-9226051 | Screening Compounds and Building Blocks |
| 1-benzyl-4-[4-(1H-tetrazol-1-yl)benzoyl]piperazine (9226051) | |||
| ChemBridge特有类药化合物/先导化合物-9226051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47171 | ChemBridge-9305194 | ChemBridge化合物-9305194 | Screening Compounds and Building Blocks |
| N-1H-benzimidazol-2-yl-2-[3-(4-fluorophenyl)-6-oxo-1(6H)-pyridazinyl]acetamide (9305194) | |||
| ChemBridge特有类药化合物/先导化合物-9305194，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47229 | ChemBridge-9337051 | ChemBridge化合物-9337051 | Screening Compounds and Building Blocks |
| N-(3,4-dimethylphenyl)-3-[3-(4-pyridinyl)-1,2,4-oxadiazol-5-yl]propanamide (9337051) | |||
| ChemBridge特有类药化合物/先导化合物-9337051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47258 | ChemBridge-10512440 | ChemBridge化合物-10512440 | Screening Compounds and Building Blocks |
| 8-methyl-2-[3-(5-methyl-1H-tetrazol-1-yl)propanoyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole (10512440) | |||
| ChemBridge特有类药化合物/先导化合物-10512440，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47259 | ChemBridge-10515300 | ChemBridge化合物-10515300 | Screening Compounds and Building Blocks |
| N,2,6-trimethyl-N-(3-pyrrolidin-1-ylbutyl)pyrimidine-4-carboxamide (10515300) | |||
| ChemBridge特有类药化合物/先导化合物-10515300，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47367 | ChemBridge-14051875 | ChemBridge化合物-14051875 | Screening Compounds and Building Blocks |
| (3S,5R)-N-[2-(acetylamino)ethyl]-N'-(2,3-dihydro-1H-inden-5-yl)-1-(1H-indol-3-ylmethyl)-3,5-piperidinedicarboxamide (14051875) | |||
| ChemBridge特有类药化合物/先导化合物-14051875，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47602 | ChemBridge-23051107 | ChemBridge化合物-23051107 | Screening Compounds and Building Blocks |
| 3-[(4-pyridin-4-ylpiperidin-1-yl)carbonyl]-4H-pyrido[1,2-a]pyrimidin-4-one (23051107) | |||
| ChemBridge特有类药化合物/先导化合物-23051107，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47738 | ChemBridge-28570051 | ChemBridge化合物-28570051 | Screening Compounds and Building Blocks |
| 1-{[1-(4-fluorophenyl)cyclopropyl]methyl}-3-piperidinol trifluoroacetate (salt) (28570051) | |||
| ChemBridge特有类药化合物/先导化合物-28570051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48315 | ChemBridge-52135051 | ChemBridge化合物-52135051 | Screening Compounds and Building Blocks |
| 5-[(3-fluorophenoxy)methyl]-N-[(3-methylpyridin-2-yl)methyl]-1H-pyrazole-3-carboxamide (52135051) | |||
| ChemBridge特有类药化合物/先导化合物-52135051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48416 | ChemBridge-56051706 | ChemBridge化合物-56051706 | Screening Compounds and Building Blocks |
| N-[rac-(3S,4R)-4-ethoxytetrahydrofuran-3-yl]-3-(3-hydroxy-3-methylbut-1-yn-1-yl)benzamide (56051706) | |||
| ChemBridge特有类药化合物/先导化合物-56051706，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48440 | ChemBridge-57205140 | ChemBridge化合物-57205140 | Screening Compounds and Building Blocks |
| 2-{[methyl(2,2,6,6-tetramethylpiperidin-4-yl)amino]methyl}benzoic acid (57205140) | |||
| ChemBridge特有类药化合物/先导化合物-57205140，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M49283 | ChemBridge-96305102 | ChemBridge化合物-96305102 | Screening Compounds and Building Blocks |
| 4-(N,N-dimethylglycyl)-7-(2-methylphenyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-9-ol (96305102) | |||
| ChemBridge特有类药化合物/先导化合物-96305102，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M50002 | ChemBridge-70405146 | ChemBridge化合物-70405146 | Screening Compounds and Building Blocks |
| 1-(cis-4-aminocyclohexyl)-N-methyl-N-[3-(1-methyl-1H-imidazol-2-yl)propyl]-1H-1,2,3-triazole-4-carboxamide (70405146) | |||
| ChemBridge特有类药化合物/先导化合物-70405146，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M54970 | ChemBridge-5528051 | ChemBridge化合物-5528051 | Screening Compounds and Building Blocks |
| N~2~-acetyl-N~1~-{[(diphenylmethyl)amino]carbonyl}isoleucinamide | |||
| ChemBridge特有类药化合物/先导化合物-5528051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M55053 | ChemBridge-7959051 | ChemBridge化合物-7959051 | Screening Compounds and Building Blocks |
| 4-(1,3-benzodioxol-5-yl)-6-chloro-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-9-carboxylic acid | |||
| ChemBridge特有类药化合物/先导化合物-7959051，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M30974 | LEDGIN6 | LEDGIN6 | HIV Protease |
| CX05168; CX04328 | |||
| LEDGIN6 (CX05168) 是一种基于喹啉的 LEDGF/p75 与 HIV 整合酶的蛋白-蛋白相互作用抑制剂。 | |||